"Probiotics" is a category, not a drug, and the effect depends entirely on the specific strain, dose, and what you're using it for. There's decent evidence in a few defined situations and a lot of hype for vague daily "gut health." Buy for a named strain and a named reason, or don't bother.
The one-paragraph version
Probiotics are live microorganisms that, in adequate amounts, can confer a health benefit — but benefits are strain-specific, so results with one product don't transfer to another S3. The strongest support is for reducing symptoms of irritable bowel syndrome (IBS) with particular strains, and for preventing antibiotic-associated diarrhea S1S2S3. Across IBS trials probiotics beat placebo overall and are generally well tolerated, but which strain is best for overall symptoms is still unsettled S1S2. For a healthy person with no specific problem, a daily probiotic is a weak bet.
What it is and how it works
Probiotics are live bacteria or yeasts — commonly Lactobacillus, Bifidobacterium, and Saccharomyces boulardii species — taken to add or support beneficial gut microbes S3. Proposed mechanisms include competing with harmful microbes, strengthening the gut barrier, producing beneficial compounds, and modulating immune and nerve signaling in the gut S3. The crucial point is that these effects are demonstrated for particular strains at particular doses, and don't generalize across the whole category S3.
What the evidence actually supports
IBS symptoms — reasonable, strain-dependent. A strain-specific systematic review and network meta-analyses find that several probiotic strains improve IBS symptoms versus placebo, with a clinically meaningful overall improvement and good tolerability; but some well-known strains showed no benefit, and the field can't yet name a single best strain for global IBS symptoms S1S2. Some products help abdominal pain or a specific IBS subtype more than overall symptoms S1S2.
Antibiotic-associated diarrhea — supported. Gastroenterology guidelines recognize specific probiotics (e.g., certain Lactobacillus strains and S. boulardii) for reducing the risk of antibiotic-associated diarrhea S3.
General "gut health," immunity, mood in healthy people — weak. Broad daily-wellness claims outrun the evidence; benefits are demonstrated for defined conditions and strains, not for vague optimization in people with no problem S3.
Who actually benefits
People with IBS (trying a strain with trial support and giving it a defined trial period), people taking a course of antibiotics who want to reduce diarrhea risk, and certain other clinician-guided situations S1S2S3. Healthy people with no GI complaint are unlikely to notice anything S3.
Dosing (standard, well-established)
There's no universal dose — it's defined per strain and product, typically expressed in colony-forming units (CFU), often in the billions per day, matched to the amount used in the trials for that strain S3. The practical, evidence-aligned approach is to pick a product that names its specific strain(s) and CFU count, matches a use with trial support, and to judge it over a defined window (commonly ~4 weeks for IBS) rather than indefinitely S1S3. Fermented foods (yogurt, kefir, sauerkraut) are a reasonable food-first option, though their strains and doses aren't standardized S3.
Safety
For generally healthy people, probiotics are well tolerated; across IBS trials they did not increase adverse events, with mild gas or bloating the most common complaint S1. The important exception: in immunocompromised, critically ill, or post-surgical patients, people with central venous catheters, and premature infants, live-organism supplements can rarely cause serious infections, so these groups should only use them under medical supervision S3. Because supplements aren't tightly regulated, actual live counts and strain identity can differ from the label, making third-party verification worthwhile S3.
The marketing myths
- "All probiotics support gut health." Benefits are strain-specific; the category label tells you almost nothing S3.
- "More CFU is better." Higher counts aren't automatically more effective; matching the studied strain and dose matters more S3.
- "Everyone should take a daily probiotic." Evidence is for defined conditions, not routine use in healthy people S3.
- "Probiotics are risk-free." True for most, but genuinely dangerous for some vulnerable patients S3.
Sources
Every reference below is a primary source cited in this guide.